A2T (p.Ala2Thr) variant of AGT (Angiotensinogen)
A2T (p.Ala2Thr) in AGT (Angiotensinogen) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.11 / 1. The record also includes population frequency data and structural context.
A2T (p.Ala2Thr) variant details
- p.Ala2Thr
- TOPMed rs1005539327
- Missense
- Variant Prioritization Score for Impact Estimate 0.114
- REVEL 0.15
- CADD 0.45
- PolyPhen-2 0.00
- SIFT 0.57
- Most common in the Non-Finnish European population (allele frequency 9e-07)
- Structural context available